Insights Into Participating in Clinical Studies for Anorexia

Not yet recruiting

• Conditions: Anorexia

• Registration Number: NCT06146075
• Lead Sponsor: Power Life Sciences Inc.

Brief Summary

Clinical trials centered on anorexia serve a pivotal function in assessing the safety and effectiveness of emerging treatments for this condition.

The primary aim revolves around meticulously scrutinizing both trial completion rates and instances of voluntary withdrawal within specific patient cohort.

Detailed Description

Not available

Study Timeline

• Status Verified: 2023-11
• Study First Submitted: 2023-11-17
• Study First Submitted QC: 2023-11-17
• Last Update Submitted: 2023-11-17
• Study First Posted: 2023-11-24
• Last Update Posted: 2023-11-24
• Study Start: 2024-12
• Primary Completion: 2025-12
• Study Completion: 2026-12

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
• Diagnosis of anorexia
• No prior treatment for anorexia

Exclusion Criteria

• Pregnant or lactating women
• Any serious and/or unstable pre-existing medical disorders
• Patients receiving any other investigational agents

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of patients who decide to enroll in an anorexia clinical research	3 months
Rate of patients who remain in an anorexia clinical trial to trial completion	12 months

Trial Locations

Locations (1)

Power Life Sciences; 🇺🇸 San Francisco, California, United States